Results 191 to 200 of about 554,435 (240)
Abemaciclib and Letrozole in Metastatic Male Breast Cancer. [PDF]
Cancer Rep (Hoboken)Schönfeld L +5 more
europepmc +1 more source
Marital status as an independent prognostic factor in male breast cancer: a SEER-based cohort study. [PDF]
Breast CancerSanli AN +4 more
europepmc +1 more source
Analysis and comparison of the burden of male breast cancer: differences between the global, China, India, and the United States. [PDF]
BMC Public HealthAn B, Che M, Liu Y, Yang X, Li Z.
europepmc +1 more source
Unveiling the comorbidity burden of male breast cancer. [PDF]
Sci RepSantos-Mejías A +7 more
europepmc +1 more source
Survival impact of adjuvant radiotherapy in early stage low risk elderly male breast cancer patients treated with breast conserving surgery. [PDF]
Sci RepXu C, Zeng C, Zhu Q, Wang Y.
europepmc +1 more source
Factors Associated With Male Breast Cancer Incidence Among Prostate Cancer Survivors: Real World Evidence From Veterans Affairs National Prostate Cancer Data Core. [PDF]
ProstateWhyne EZ +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Clinical Journal of Oncology Nursing, 2004
Male breast cancer (MBC) is a rare disease, accounting for less than 1% of all breast cancers. It is an infrequent, but serious clinical problem. This paper discusses epidemiology, potential risk factors, tumor histopathology, clinical features and treatment strategies of the disease.
Loerzel, Victoria Wochna +1 more
openaire +5 more sources
Male breast cancer (MBC) is a rare disease, accounting for less than 1% of all breast cancers. It is an infrequent, but serious clinical problem. This paper discusses epidemiology, potential risk factors, tumor histopathology, clinical features and treatment strategies of the disease.
Loerzel, Victoria Wochna +1 more
openaire +5 more sources
Oncology, 1974
42 cases of male breast cancer were studied. The disease is diagnosed in males at a later stage than in females. The prognosis of this disease in males is more favorable than in females: in stage I there is an 83% 5-year survival, while in stage II there is 62% 5-year survival.
N, Walach, A, Hochman
openaire +2 more sources
42 cases of male breast cancer were studied. The disease is diagnosed in males at a later stage than in females. The prognosis of this disease in males is more favorable than in females: in stage I there is an 83% 5-year survival, while in stage II there is 62% 5-year survival.
N, Walach, A, Hochman
openaire +2 more sources
The Lancet, 2006
Occurrence of male breast cancer, a rare disease, peaks at age 71 years. Familial cases usually have BRCA2 rather than BRCA1 mutations. Occupational risks include high temperature environments and exhaust fumes, but electromagnetic fields have not been implicated.
Ian S, Fentiman +2 more
openaire +3 more sources
Occurrence of male breast cancer, a rare disease, peaks at age 71 years. Familial cases usually have BRCA2 rather than BRCA1 mutations. Occupational risks include high temperature environments and exhaust fumes, but electromagnetic fields have not been implicated.
Ian S, Fentiman +2 more
openaire +3 more sources